T. Rowe Price Associates’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,324,274
| Closed | -$9.79M | – | 2962 |
|
|
2023
Q4 | $9.79M | Sell |
2,324,274
-863,425
| -27% | -$3.64M | ﹤0.01% | 1099 |
|
|
2023
Q3 | $21.8M | Sell |
3,187,699
-376,327
| -11% | -$2.57M | ﹤0.01% | 895 |
|
|
2023
Q2 | $37.1M | Sell |
3,564,026
-249,870
| -7% | -$2.6M | 0.01% | 783 |
|
|
2023
Q1 | $26.6M | Buy |
3,813,896
+3,260,031
| +589% | +$22.7M | ﹤0.01% | 847 |
|
|
2022
Q4 | $3.34M | Buy |
+553,865
| New | +$3.34M | ﹤0.01% | 1273 |
|
|
2022
Q2 | – | Sell |
-450,642
| Closed | -$8.84M | – | 2964 |
|
|
2022
Q1 | $8.84M | Sell |
450,642
-53,506
| -11% | -$1.05M | ﹤0.01% | 1381 |
|
|
2021
Q4 | $17.3M | Buy |
504,148
+20,777
| +4% | +$713K | ﹤0.01% | 1315 |
|
|
2021
Q3 | $26.4M | Buy |
483,371
+480,297
| +15,624% | +$26.2M | ﹤0.01% | 1227 |
|
|
2021
Q2 | $226K | Sell |
3,074
-1,367,014
| -100% | -$101M | ﹤0.01% | 2674 |
|
|
2021
Q1 | $125M | Buy |
1,370,088
+102,290
| +8% | +$9.36M | 0.01% | 699 |
|
|
2020
Q4 | $103M | Buy |
1,267,798
+65,377
| +5% | +$5.3M | 0.01% | 717 |
|
|
2020
Q3 | $56M | Buy |
+1,202,421
| New | +$56M | 0.01% | 829 |
|